Longboard Pharmaceuticals, Inc. Balance Sheet

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Prepaid expenses and other current assets
Total current assets
Right-of-use assets
Property and equipment
Other long-term assets
Deferred financing costs
Total assets

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable
Accrued research and development expenses
Accrued compensation and related expenses
Accrued other expenses
Intersegment Eliminations
Total accrued other expenses
Right-of-use liabilities, current portion
Total current liabilities
Right-of-use liabilities, net of current portion
Temporary equity, value
Series A Convertible Preferred Stock
Total temporary equity, value

Stockholders' equity:
Preferred Stock, Value, Issued
Common Stock, Value, Issued
Non-Voting Common Stock
Voting Common Stock
Total common Stock, Value, Issued
Additional paid-in-capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Comments